As India charges forward with its ambitious renewable energy goals, the biofuel sector is emerging as a crucial player. In this dynamic landscape, Trualt Bioenergy Limited is stepping into the spotlight with its upcoming Initial Public Offering (IPO). This blog post offers a comprehensive look at Trualt Bioenergy, its market positioning, financial health, and everything investors need to know about its highly anticipated public offering.
Established in 2021, Trualt Bioenergy Limited has swiftly become a significant entity in India's biofuel production. The company's core focus is the ethanol sector, where it boasts an impressive installed capacity of 2,000 kiloliters per day (KLPD), positioning it as one of the nation's largest ethanol producers. In the fiscal year 2025, the company commanded a notable 3.6% market share in ethanol production capacity.
Beyond ethanol, Trualt Bioenergy has diversified its operations into compressed biogas (CBG) production. Its subsidiary, Leafinity, currently operates a CBG plant with a capacity of 10.20 tonnes per day (TPD). The company is actively pursuing expansion in this segment, evident from strategic Memorandums of Understanding (MoUs) with a prominent Japanese Gas company and Sumitomo Corporation Asia & Oceania Pte. Ltd.
Operating five distillery units in Karnataka, four of which utilize molasses and syrup-based feedstocks, Trualt Bioenergy is strategically positioned. Looking ahead, the company is poised to venture into advanced verticals, including second-generation ethanol, sustainable aviation fuel, and specialized biochemicals like Mevalonolactone (MVL).
Trualt Bioenergy's strong market presence is underpinned by several strategic strengths:
The Trualt Bioenergy IPO is a book-built issue valued at ₹839.28 crores. This offering comprises a fresh issuance of 1.51 crore shares, amounting to ₹750.00 crores, alongside an Offer for Sale (OFS) of 0.18 crore shares, totaling ₹89.28 crores.
Mark your calendars with these important dates for the Trualt Bioenergy IPO:
| Aspect | Detail |
|---|---|
| Issue Type | Book Building IPO |
| Face Value | ₹10 per share |
| Price Band | ₹472 to ₹496 per share |
| Total Issue Size | 1,69,20,967 shares (₹839.28 Cr) |
| Fresh Issue | 1,51,20,967 shares (₹750.00 Cr) |
| Offer for Sale | 18,00,000 shares (₹89.28 Cr) |
| Listing At | BSE, NSE |
| Cut-off for UPI mandate confirmation | 5 PM on Mon, Sep 29, 2025 |
The lot size for an application is 30 shares. Here's a breakdown of the minimum and maximum investment across different investor categories:
| Investor Category | Lots | Shares | Amount (at upper price band) |
|---|---|---|---|
| Retail (Minimum) | 1 | 30 | ₹14,880 |
| Retail (Maximum) | 13 | 390 | ₹1,93,440 |
| Small HNI (Minimum) | 14 | 420 | ₹2,08,320 |
| Small HNI (Maximum) | 67 | 2,010 | ₹9,96,960 |
| Big HNI (Minimum) | 68 | 2,040 | ₹10,11,840 |
The issue has specific reservations for different investor categories:
Trualt Bioenergy Limited has demonstrated robust financial growth. Between March 31, 2024, and March 31, 2025, the company's revenue surged by 54%, while its Profit After Tax (PAT) witnessed a remarkable increase of 361%.
| Particulars (₹ Crore) | March 31, 2025 | March 31, 2024 |
|---|---|---|
| Assets | 3,029.73 | 2,419.08 |
| Total Income | 1,968.53 | 1,280.19 |
| Profit After Tax (PAT) | 146.64 | 31.81 |
| EBITDA | 309.14 | 188.09 |
| Net Worth | 769.00 | 264.61 |
| Total Borrowing | 1,549.68 | 1,684.68 |
As of March 31, 2025, Trualt Bioenergy's market capitalization stands at ₹4253.33 Crores. Here are some other crucial performance indicators:
| Key Performance Indicator (KPI) | Value (as of Mar 31, 2025) |
|---|---|
| Return on Equity (ROE) | 28.27% |
| Return on Capital Employed (ROCE) | 10.88% |
| Debt/Equity Ratio | 2.02 |
| Return on Net Worth (RoNW) | 19.07% |
| PAT Margin | 7.69% |
| EBITDA Margin | 16.20% |
| Price to Book Value | 4.56 |
| Valuation Metric | Pre-IPO | Post-IPO |
|---|---|---|
| Earnings Per Share (EPS) | ₹20.76 | ₹17.10 |
| Price-to-Earnings (P/E) Ratio | 23.89x | 29.01x |
Trualt Bioenergy plans to utilize the net proceeds from the IPO for strategic growth initiatives:
The company is promoted by Vijaykumar Murugesh Nirani, Vishal Nirani, and Sushmitha Vijaykumar Nirani, who are instrumental in guiding its strategic direction.
| Holding Stage | Percentage of Shares |
|---|---|
| Promoter Holding Pre-Issue | 88.20% |
| Promoter Holding Post-Issue | 70.55% |
The change in promoter holding reflects the equity dilution necessary for the public offering.
The success of an IPO relies on a strong team of financial intermediaries. For Trualt Bioenergy, these include:
Understanding the company's internal and external factors is crucial for investors. Here's a brief SWOT analysis:
For direct inquiries or more information, you can reach out to the company:
Trualt Bioenergy Limited presents an intriguing investment opportunity in India's rapidly growing biofuel sector. With its strong market position, robust financial performance, and clear growth objectives, the company is well-aligned with the nation's sustainable development goals. As with any investment, it is recommended that potential investors conduct thorough due diligence, review the offer documents carefully, and consult with a financial advisor to make informed decisions. The biofuel industry is dynamic and holds significant potential, and Trualt Bioenergy appears to be a key player shaping its future.
For Advertising Queries, reach us at contactus@publiclisting.in
IPO Data News and Insights
Made in India
A Product by Saubhagya Samridhi